secwatch / observer
8-K filed March 22, 2022, 7:59 PM ET ticker TRDA CIK 0001689375
other material confidence high sentiment neutral materiality 0.60

Entrada Therapeutics signs 10-year lease for ~81,442 sq ft HQ in Boston

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-22-036320
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.